Responses
Scientific Abstracts
Poster Presentations
Posters
Spondyloarthritis – treatment
THU0262 Sclerostin does not predict radiographic progression in patients on anti-tnf therapy – new results from the european ankylosing spondylitis (AS) infliximab cohort (EASIC)
Compose a Response to This Article
Other responses
No responses have been published for this article.